Medical Ikkou Group Co.,Ltd. [3353.T]
TOKYO, Mar 26 (Pulse News Wire) – Medical Ikkou Group CO.,LTD. (3353.T) announced today that its board of directors has decided on eight candidates for director positions effective May 20, 2026.
Formal approval will follow at the annual shareholders' meeting scheduled for May 20, 2026, and subsequent board meetings. Among the appointed candidates, Norihiro Minano, CEO, and Yoshiharu Sakurai, executive vice president, will retain their roles. Kiyosuke Oda, previously an advisor at Mitsubishi UFJ Bank, was newly appointed as senior executive officer and head of finance and IR.
Additionally, four external directors—Keiko Horino, Shigeichi Kuwahara, Yutaka Horiguchi, and Sumire Sawada—are set to continue their service. Horino, Kuwahara, Horiguchi, and Sawada are also considered independent director candidates according to Article 436-2 of the Tokyo Stock Exchange's listing regulations. He became the head of the same department in May 2025, concurrently holding the position of managing director at Medical Ikkou Corporation.
In March 2024, he had served as an advisor at Mitsubishi UFJ Bank’s Fukuyama branch prior to his move to Medical Ikkou Group.
🟢 Confidence: High AI-translated content.